SC 13G Filing

Company

Actinium Pharmaceuticals, Inc.

Filed

August 4, 2017

Accession Number

0000919574-17-005752

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →